Proton pump inhibitors and clopidogrel - hazardous drug interaction or hazardous interpretation of data?
作者信息
Moayyedi Paul, Sadowski Daniel C
出版信息
Can J Gastroenterol. 2009 Apr;23(4):251-2. doi: 10.1155/2009/868946.
Abstract
摘要
相似文献
1
Proton pump inhibitors and clopidogrel - hazardous drug interaction or hazardous interpretation of data?
Can J Gastroenterol. 2009 Apr;23(4):251-2. doi: 10.1155/2009/868946.
2
The prevalence of co-administration of clopidogrel and proton pump inhibitors.
Qual Prim Care. 2011;19(1):35-42.
3
Cardiovascular and gastrointestinal events of three antiplatelet therapies: clopidogrel, clopidogrel plus proton-pump inhibitors, and aspirin plus proton-pump inhibitors in patients with previous gastrointestinal bleeding.
J Gastroenterol. 2011 Jan;46(1):39-45. doi: 10.1007/s00535-010-0299-0. Epub 2010 Sep 2.
4
The clinical relevance of the clopidogrel-proton pump inhibitor interaction.
J Cardiovasc Transl Res. 2012 Aug;5(4):547-52. doi: 10.1007/s12265-011-9334-7. Epub 2012 Feb 14.
5
[Prevention of GI bleeding due to antiplatelet agents: a labyrinth!].
Presse Med. 2009 Dec;38(12):1722-6. doi: 10.1016/j.lpm.2009.09.011. Epub 2009 Nov 13.
6
[Efficacy and safety of concomitant use of rabeprazole during dual-antiplatelet therapy with clopidogrel and aspirin after drug-eluting stent implantation: a retrospective cohort study].
Yakugaku Zasshi. 2010 Dec;130(12):1743-50. doi: 10.1248/yakushi.130.1743.
7
ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.
Am J Gastroenterol. 2010 Dec;105(12):2533-49. doi: 10.1038/ajg.2010.445.
8
Proton pump inhibitors and clopidogrel.
Cardiovasc Ther. 2010 Jun;28(3):169-76. doi: 10.1111/j.1755-5922.2010.00143.x. Epub 2010 Mar 25.
9
Individualised PPI prescription in patients on combination antiplatelet therapy and upper gastrointestinal events after percutaneous coronary intervention: a cohort study.
Wien Med Wochenschr. 2012 Feb;162(3-4):67-73. doi: 10.1007/s10354-012-0056-5.
10
[Interaction between clopidogrel and proton pump inhibitors].
Ned Tijdschr Geneeskd. 2011;155(28):A2442.
引用本文的文献
1
What you need to know when you prescribe a proton pump inhibitor.
Frontline Gastroenterol. 2011 Oct;2(4):199-205. doi: 10.1136/flgastro-2011-100006. Epub 2011 Jun 24.
2
Diagnosis and therapy of non-variceal upper gastrointestinal bleeding.
World J Gastrointest Pharmacol Ther. 2015 Nov 6;6(4):172-82. doi: 10.4292/wjgpt.v6.i4.172.
3
Prognosis of concomitant users of clopidogrel and proton-pump inhibitors in a high-risk population for upper gastrointestinal bleeding.
BMC Pharmacol Toxicol. 2014 Apr 15;15:22. doi: 10.1186/2050-6511-15-22.
4
The risks of PPI therapy.
Nat Rev Gastroenterol Hepatol. 2012 Feb 14;9(3):132-9. doi: 10.1038/nrgastro.2011.272.
本文引用的文献
1
Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome.
JAMA. 2009 Mar 4;301(9):937-44. doi: 10.1001/jama.2009.261.
2
A population-based study of the drug interaction between proton pump inhibitors and clopidogrel.
CMAJ. 2009 Mar 31;180(7):713-8. doi: 10.1503/cmaj.082001. Epub 2009 Jan 28.
3
Cytochrome p-450 polymorphisms and response to clopidogrel.
N Engl J Med. 2009 Jan 22;360(4):354-62. doi: 10.1056/NEJMoa0809171. Epub 2008 Dec 22.
4
Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks.
Aliment Pharmacol Ther. 2009 Mar 1;29(5):481-96. doi: 10.1111/j.1365-2036.2008.03905.x. Epub 2008 Nov 27.
5
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
Circulation. 2008 Oct 28;118(18):1894-909. doi: 10.1161/CIRCULATIONAHA.108.191087. Epub 2008 Oct 3.
6
Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.
J Am Coll Cardiol. 2008 Jan 22;51(3):256-60. doi: 10.1016/j.jacc.2007.06.064.
7
Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations.
Gut. 2006 Dec;55(12):1731-8. doi: 10.1136/gut.2005.080754. Epub 2006 May 10.
8
Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding.
N Engl J Med. 2005 Jan 20;352(3):238-44. doi: 10.1056/NEJMoa042087.
9
Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.
Drug Metab Dispos. 2004 Aug;32(8):821-7. doi: 10.1124/dmd.32.8.821.
10
Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction.
Circulation. 2004 Jun 29;109(25):3171-5. doi: 10.1161/01.CIR.0000130846.46168.03. Epub 2004 Jun 7.
Zotero 插件